| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 05/31/2006 | CN1780615A The use of azetidinecarboxamide derivatives in therapy. |
| 05/31/2006 | CN1780606A Fibrate tablet and method for the production thereof |
| 05/31/2006 | CN1778391A Safety and high-efficient compound hypolipidemic medicine |
| 05/31/2006 | CN1778380A Extraction of Job's tears seeds, its component and curative effect |
| 05/31/2006 | CN1778376A Medicine composition for lowering blood fat |
| 05/31/2006 | CN1778373A Health-care composition |
| 05/31/2006 | CN1778358A Medicine for treating prostatic accrementition and its preparation |
| 05/31/2006 | CN1778355A Chinese medicine composition for treating diabetes mellitus |
| 05/31/2006 | CN1778324A Effective part of nightshadeleaf ironweed for antiscolic medicines and its preparation and use |
| 05/31/2006 | CN1778311A Polysaccharid glucoside Chinese medicinal oral preparation and its making method thereof |
| 05/31/2006 | CN1778309A Use of arctiin and its aglycon in preparation of medicines for diabetes and nephrosis |
| 05/31/2006 | CN1778303A Use of rhizoma anemarrhenae total saponin in preparation of medicine for treating hyperlipemia and arterial sclerosis |
| 05/31/2006 | CN1778296A Long-acting preparation for tatin medicine |
| 05/31/2006 | CN1778294A Butin and its derivative and its use in preparation of pigmental metabolic disease medicine |
| 05/31/2006 | CN1778293A Rutin effervesce agent composition |
| 05/31/2006 | CN1778207A Red bean beverage for reducing weight |
| 05/31/2006 | CN1257893C PPAR full activator of amino acids of aralkyl possessing excellent activity for lowering sugar and ester |
| 05/31/2006 | CN1257892C New indole derivatives with 5-HT6 receptor affinity |
| 05/31/2006 | CN1257891C Nitrogenous five-membered ring compounds |
| 05/31/2006 | CN1257734C Tangnaikang granule and its preparing process |
| 05/31/2006 | CN1257728C Ready made traditional Chinese medicine for treating diabetes and its preparation method |
| 05/31/2006 | CN1257724C Composition for preventing and treating diabets mellitus |
| 05/30/2006 | USRE39112 Purine derivatives and adenosine A2 receptor antagonists serving as preventives/remedies for diabetes |
| 05/30/2006 | US7053245 N-acylamino benzyl ether derivatives |
| 05/30/2006 | US7053215 For therapy of inflammatory and immunoregulatory disorders and diseases, such as multiple sclerosis, rheumatoid arthritis and type I diabetes |
| 05/30/2006 | US7053113 Mannich base prodrugs of 3-(pyrrol-2-yl-methylidene)-2-indolinone derivatives |
| 05/30/2006 | US7053110 Dietetics; osteoporosis; muscular disorders |
| 05/30/2006 | US7053108 Indoline compounds |
| 05/30/2006 | US7053103 A pyrazolo[3,4-B]pyridine derivatives; corticotropin releasing factor receptor antagonists; treating stress-related illnesses, mood disorders, eating disorders, stress-induced gastrointestinal dysfunctions, neurodegenerative diseases, and neuropsychiatric disorders |
| 05/30/2006 | US7053099 3,4-dihydro-(1H)quinazolin-2-one compounds as CSBP/p38 kinase inhibitors |
| 05/30/2006 | US7053098 3,4-Dihydro-(1H) quinazolin-2-one compounds as CSBP/P38 kinase inhibitors |
| 05/30/2006 | US7053090 Antiinflammatory agents; antihistamines; skin disorders; antiarthritic agents; antidiabetic agents; autoimmune disease |
| 05/30/2006 | US7053086 For cancer therapy |
| 05/30/2006 | US7053060 Glucopyranosyloxybenzylbenzene derivatives, medicinal compositions containing the same and intermediates in the production thereof |
| 05/30/2006 | US7053057 Caspase inhibitors and uses thereof |
| 05/30/2006 | US7053056 Antiinflammatory agents; autoimmune disease; antiischemic agents |
| 05/30/2006 | US7053055 Compounds of unstable DP IV-inhibitors |
| 05/30/2006 | US7052906 Synthetic transmembrane components |
| 05/30/2006 | US7052900 Saccharomyces cerevisiae yeast strain with functional expression of a Glut transporter |
| 05/30/2006 | US7052860 Identification of Actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases |
| 05/30/2006 | US7052691 Vascular Endothelial Growth Factors (VEGF) by injection; for decreased serum glucose concentrations, improved glucose tolerance, increased insulin sensitivity, and reduced hyperinsulinemia |
| 05/30/2006 | CA2413235C Processing method of lactonization in the preparation of statins |
| 05/30/2006 | CA2375908C Highly selective norepinephrine reuptake inhibitors and methods of using the same |
| 05/30/2006 | CA2354605C Diazabicyclooctane derivatives and therapeutic uses thereof |
| 05/30/2006 | CA2345582C Process for the preparation of the mesylate salt trihydrate of 1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidin-1-yl)-1-propanol |
| 05/30/2006 | CA2321380C 6-azauracil derivatives as thyroid receptor ligands |
| 05/30/2006 | CA2117377C Substituted amino alkyl compounds |
| 05/30/2006 | CA2085831C Polymers and oligomers of bile acid derivatives, process for their preparation and their use as pharmaceuticals |
| 05/26/2006 | WO2006055725A2 Substituted amino acids as protein tyrosine phosphatase inhibitors |
| 05/26/2006 | WO2006055625A2 Heterocyclylbiphenyl derivates as protein tyrosine phosphatase inhibitors |
| 05/26/2006 | WO2006055526A2 Compositions useful to treat ocular neovascular diseases and macular degeneration |
| 05/26/2006 | WO2006055511A2 Stable tablet formulation of tetrahydrobiopterin |
| 05/26/2006 | WO2006055435A1 2-aminonaphthalene derivatives and related glycogen phosphorylase inhibitors |
| 05/26/2006 | WO2006055187A1 Sulfonyl-substituted bicyclic compounds as modulators of ppar |
| 05/26/2006 | WO2006054757A1 Caspase inhibitor |
| 05/26/2006 | WO2006054641A1 Gpr7-selective ligand and use thereof |
| 05/26/2006 | WO2006054629A1 1-SUBSTITUTED-3-β-D-GLUCOPYRANOSYLATED NITROGENOUS HETERO- CYCLIC COMPOUNDS AND MEDICINES CONTAINING THE SAME |
| 05/26/2006 | WO2006054555A1 Medicinal composition for treating cancer or diabetes |
| 05/26/2006 | WO2006054396A1 Cyclic isodityrosine derivatives |
| 05/26/2006 | WO2006054370A1 Gluconeogenesis inhibiting agent |
| 05/26/2006 | WO2006054298A2 Glycogen synthase kinase-3 inhibitors |
| 05/26/2006 | WO2006054166A1 Drugs and prodrugs useful for the treatment of energy balance in ruminants |
| 05/26/2006 | WO2006053766A1 Methods for purifying trans-(-)-δ9-tetrahydrocannabinol and trans-(+)-δ9-tetrahydrocannabinol |
| 05/26/2006 | WO2006053647A1 Satiety emulsions and food compositions |
| 05/26/2006 | WO2006053390A1 A method of modulating b cell functioning |
| 05/26/2006 | WO2006053379A1 Improved nutraceutical composition |
| 05/26/2006 | WO2006034446A3 Pyridine derivatives for inhibiting human stearoyl-coa-desaturase |
| 05/26/2006 | WO2006031786A3 Protein a compositions and methods of use |
| 05/26/2006 | WO2006029179A3 Substituted piperazine compounds and their use as fatty acid oxidation inhibitors |
| 05/26/2006 | WO2006027052A3 (halobenzyloxy) benzylamino-propanamides as sodium and/or calcium channel selective modulators |
| 05/26/2006 | WO2006024931A3 Therapeutic combinations comprising a selective estrogen receptor modulator and a selective androgen receptor modulator |
| 05/26/2006 | WO2005046796A3 Combinations of a cholesterol biosynthesis inhibitor and a soluble fiber for the treatment of conditions associated with elevated cholesterol levels |
| 05/26/2006 | WO2005034650A8 Weight-loss supplement |
| 05/26/2006 | CA2588963A1 1-substituted-3-.beta.-d-glucopyranosylated nitrogenous hetero-cyclic compounds and medicines containing the same |
| 05/26/2006 | CA2588776A1 Substituted amino carboxylic acids |
| 05/26/2006 | CA2587957A1 Methods for purifying trans-(-)-delta-9-tetrahydrocannabinol and trans-(+)-delta-9-tetrahydrocannabinol |
| 05/26/2006 | CA2587732A1 Glycogen synthase kinase-3 inhibitors |
| 05/26/2006 | CA2587690A1 Drugs and prodrugs useful for the treatment of energy balance in ruminants |
| 05/26/2006 | CA2587627A1 Desacyl ghrelin antibodies and therapeutic uses thereof |
| 05/26/2006 | CA2587566A1 Heterocyclylbiphenyl derivates as protein tyrosine phosphatase inhibitors |
| 05/26/2006 | CA2587484A1 Satiety emulsions and food compositions |
| 05/26/2006 | CA2587407A1 A method of modulating b cell functioning |
| 05/26/2006 | CA2587398A1 Gpr7-selective ligand and use thereof |
| 05/26/2006 | CA2587391A1 Compositions useful to treat ocular neovascular diseases and macular degeneration |
| 05/26/2006 | CA2586358A1 Use of tetrahydrocannabivarin (thcv) as neutral antagonist of the cb1 cannabinoid receptors |
| 05/26/2006 | CA2585172A1 Sulfonyl-substituted bicyclic compounds as modulators of ppar |
| 05/26/2006 | CA2581814A1 Stable tablet formulation of tetrahydrobiopterin |
| 05/25/2006 | WO2006029577A9 Methods and compositions for the treatment of hyperlipidemia |
| 05/25/2006 | US20060111445 Novel carboxylic acids and derivatives for the treatment of and preventing diabetes and dyslipidaemia |
| 05/25/2006 | US20060111425 To treat diseases of respiratory, urinary and gastrointestinal systems; highly selective; significant potency; (2R,2S)(1 alpha ,5 alpha ,6 alpha )-N-{-[4-(1,3-dioxo-1,3-dihydro-isoindol-2-yl)-butyl]-3-azabicyclo[3.1.0]hex-6-yl-methyl}-2-hydroxy-2-cyclopentyl-2-phenylacetamide |
| 05/25/2006 | US20060111424 Treating nuclear hormone receptor-associated conditions such as cancer and immune disorders; (3a alpha ,4 alpha ,7 alpha ,7a alpha )-2-(3-Chloro-4-hydroxyphenyl)hexahydro-4,7-methano-1H-isoindole-1,3(2H)-dione |
| 05/25/2006 | US20060111407 Association between a heterocyclic compound stimulating lipid and carbohydrate metabolisms and an antioxidant agent for treating obesity |
| 05/25/2006 | US20060111406 Amide linker peroxisome proliferator activated receptor modulators |
| 05/25/2006 | US20060111400 Piperidinetriol derivatives as inhibitors of glycosylceramidsynthase |
| 05/25/2006 | US20060111397 Methods and compositions for treating diseases associated with excesses in ACE |
| 05/25/2006 | US20060111390 Azaindoles as inhibitors of c-jun n-terminal kinases |
| 05/25/2006 | US20060111380 4-(2-naphtyl)-2-[3-oxospiro[isobenzofuran-1 (3H), 4'-piperidin]-1'-yl]-1H-imidazole, 4-(4-bromophenyl)-2-[3-oxospiro[isobenzofuran-1(3H),4'-piperidin]-1-yl]-1H imidazole; metabolic, genitalor reproductive, gastro-intestinal, respiratory system disorders, antiinflammatory agent or glaucoma; cyclization |
| 05/25/2006 | US20060111375 Compound having tgfß inhibitory activity and medicinal composition containing the same |
| 05/25/2006 | US20060111368 Phosphodiesterase inhibitor |
| 05/25/2006 | US20060111366 Pharmaceutical use of substituted amides |